about
STAT5-regulated microRNA-193b controls haematopoietic stem and progenitor cell expansion by modulating cytokine receptor signalling.TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation.Adaptor protein Lnk associates with Tyr(568) in c-KitAdaptor protein Lnk inhibits c-Fms-mediated macrophage functionAdaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signalingAcute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscape.Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia.Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation.Plastic CD34 and CD38 expression in adult B-cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations.[Characterization and economic impact of medical patients presenting at the emergency department of an university hospital].Construction and application of an inducible system for homogenous expression levels in bulk cell linesHoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid LeukemiaBCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cellsWhole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype.Ubiquitination and selective autophagyPotential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center.Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia.The European LeukemiaNet: achievements and perspectives.Feasibility of azacitidine added to standard chemotherapy in older patients with acute myeloid leukemia--a randomised SAL pilot study.SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trialCD133-targeted gene transfer into long-term repopulating hematopoietic stem cellsQuantitative mass spectrometric profiling of cancer-cell proteomes derived from liquid and solid tumors.Antifungal management and resource use in patients with acute myeloid leukaemia after chemotherapy--retrospective analysis of changes over 3 yr in a German hospital.Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cells.Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip.Karyotype complexity and prognosis in acute myeloid leukemia.Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry.The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survivalNew influenza A/H1N1 ("swine flu"): information needs of airport passengers and staff.HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling.ATR inhibition rewires cellular signaling networks induced by replication stress.The Phosphatases STS1 and STS2 Regulate Hematopoietic Stem and Progenitor Cell Fitness.FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation.Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.Cutting edge: feed-forward activation of phospholipase Cγ2 via C2 domain-mediated binding to SLP65.β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis.AML1/ETO induces self-renewal in hematopoietic progenitor cells via the Groucho-related amino-terminal AES protein.Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians.
P50
Q27317710-B301296D-A446-4904-82DB-747155E64218Q27853319-FEAF5C2A-E33F-4F79-A6A6-DB08600BB242Q28285515-9893D903-75C1-4F16-B3FF-E52B7E729C1AQ28285990-8B2B9EF1-AD93-47C5-8979-12FE8B82AA79Q28305099-95D25A00-7B4F-4010-B955-487642019973Q30313288-8D89BB00-ED19-4BA3-97A4-4BEA585B97A7Q30313615-2CB9F1BC-6702-4B4D-BD2A-D18A0E8D1EADQ30399755-159E0874-9F42-4967-9851-C1E40B6DFBC8Q30840810-112BB065-55BF-4300-AF4B-5CF241E1B9A6Q33162943-ADD3B46E-166E-4F8B-8F6C-A29B44A4CA34Q33489593-AF2070CA-7D5E-49C9-B67E-7653D38B8B95Q33558976-CEB9AEEF-F56E-435C-9465-C23B7C8E6AFCQ33806036-4ED7BB4B-6A5E-490C-9AF3-68C2931564D9Q34225646-9B12166D-00E4-4A3A-85D9-390071755BD7Q34283289-01AAF0CD-EB83-4748-BC94-60A6F31DDA75Q34308310-91D959FE-AA0D-4612-95B8-D905D141891CQ34310541-7D1B2203-641A-43B1-ACC6-E0918ECD0FA2Q34451619-D8E2EC34-D4E8-4666-ABF7-DAAE1E945210Q34541052-270C6FA9-DD4C-4473-8ABF-145026E0BF20Q34547626-7EC4BBC3-4DA4-4044-B28C-8F44577BBBE1Q34737471-092FA400-8461-44B6-9525-165862E6DB2AQ35238704-42D554FA-9368-430F-8CDA-5645BF63531DQ35600155-D7F02FF3-41CF-490D-ABC8-CF038C48941EQ35700698-F95B0236-92FE-4960-86CA-A4402E837BC2Q36304111-90F46624-4DB7-4634-B876-9512C72C0705Q36478470-20CA0085-6F4C-4D6E-962E-82FBDCF5DD7AQ36548075-4758C6AC-52B9-4418-A618-4025E3ED0EA1Q36654317-BE59E698-FDAF-4574-8A40-90D9980246F5Q36842360-F87638FC-74D2-491D-AFE0-5B92FCA4815CQ36931139-78D23630-9E01-43B7-BC8D-D81CB4EC9A04Q37087076-49DCBD57-1EF0-4C14-9211-CF94C726F115Q38722432-D9749719-EEDD-4F46-80DE-CD085119C1FCQ38819342-2B889E2B-5417-461C-84E7-C2984526E678Q38835640-4C720B2B-F258-4D5E-BAFE-6D721E9C3779Q38918168-2989904E-2814-46A0-917B-4C814EBA2E93Q39067635-E924A141-05C1-4945-AB0B-CDB29DD70DE7Q39069271-2A60AFFA-3919-4CA6-B4A1-13BE134337F4Q39178701-E84B3237-D165-4B93-9D85-6B8151A10117Q39606087-3FE50787-ED2D-41F5-8A8E-11184A6DA2D5Q39661740-0A0BD3EC-BCE0-44AB-9C33-F50965C601FB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hubert Serve
@ast
Hubert Serve
@en
Hubert Serve
@es
Hubert Serve
@nl
Hubert Serve
@sl
type
label
Hubert Serve
@ast
Hubert Serve
@en
Hubert Serve
@es
Hubert Serve
@nl
Hubert Serve
@sl
prefLabel
Hubert Serve
@ast
Hubert Serve
@en
Hubert Serve
@es
Hubert Serve
@nl
Hubert Serve
@sl
P108
P106
P108
P21
P31
P496
0000-0001-8472-5516